Table 4.
Diagnostic Group | Mexico City 1980–19919/ | Mexico City 1992–199310/ | Mexico City 1996–2001 | USA-SEER White 1983–19922/ | German Federal Republic 1985–19902/ | France 1983–19923/ | Cuba 1986–19905/ | |||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
I. Leukemias | 1706 | 34.9 | 78 | 39.2 | 784 | 46.1 | 1757 | 30.7 | 2422 | 34.4 | 746 | 29.4 | 454 | 30.7 |
II. Lymphomas** | 888 | 18.2 | 34 | 17.6 | 194 | 11.4 | 616 | 10.7 | 781 | 11.1 | 310 | 12.2 | 271 | 18.3 |
Hodgkin disease | 524 | 10.7 | 18 | 9.0 | 65 | 3.8 | 259 | 4.5 | 279 | 4.0 | 103 | 4.1 | 84 | 5.7 |
Non-Hodgkin lymphoma | 364 | 7.5 | 16 | 8.6 | 129 | 7.6 | 357 | 6.2 | 502 | 7.1 | 207 | 8.1 | 187 | 12.6 |
III. CNST | 496 | 10.2 | 25 | 12.6 | 197 | 11.6 | 1222 | 21.4 | 1392 | 19.8 | 538 | 21.2 | 223 | 15.1 |
IV. SNST | 133 | 2.7 | 6 | 3.0 | 39 | 2.3 | 469 | 8.2 | 552 | 7.8 | 244 | 9.6 | 104 | 7.0 |
V. Retinoblastoma | 420 | 8.6 | 5 | 2.5 | 73 | 4.3 | 172 | 3.0 | 208 | 2.9 | 61 | 2.4 | 40 | 2.7 |
VI. Renal Tumors | 279 | 5.7 | 9 | 4.5 | 71 | 4.2 | 366 | 6.4 | 464 | 6.6 | 152 | 5.9 | 69 | 4.7 |
VII. Hepatic Tumors | 70 | 1.4 | 1 | 0.5 | 30 | 1.8 | 83 | 1.5 | 82 | 1.2 | 23 | 0.9 | 21 | 1.4 |
VIII. Bone Tumors | 321 | 6.6 | 9 | 4.5 | 97 | 5.7 | 267 | 4.7 | 359 | 5.1 | 129 | 5.1 | 87 | 5.9 |
IX. Soft Tissue Sarcomas | 238 | 4.9 | 10 | 5.0 | 89 | 5.2 | 387 | 6.8 | 492 | 7.0 | 154 | 6.1 | 91 | 6.2 |
X. Germ Cell Tumors | 256 | 5.2 | 17 | 8.6 | 110 | 6.5 | 165 | 2.9 | 222 | 3.2 | 71 | 2.8 | 34 | 2.3 |
XI. Carcinomas | 55 | 1.1 | 3 | 1.5 | 18 | 1.1 | 193 | 3.4 | 55 | 0.8 | 108 | 4.3 | 55 | 3.7 |
XII. Nonspecific | 18 | 0.4 | 0 | 0 | 0 | 0.0 | 21 | 0.4 | 7 | 0.1 | 2 | 0.1 | 29 | 2.0 |
Total | 4880 | 100 | 198 | 100 | 1702 | 100 | 5718 | 100 | 7036 | 100 | 2538 | 100 | 1478 | 100 |
Note: Numbers in circles indicate the five highest frequencies, in descending order *Children 0–14 years **40 cases of histiocytosis were not included CNST: central nervous system tumors SNST: sympathetic nervous system tumor References 2,3,5,9,10.